Corneal Cross-Linking, WGECC First to Offer New Innovative Treatment!
West Georgia Eye Care Center is excited to be the first in our region to offer Corneal Cross-Linking (KXL)! We have been the first in the region with multiple technologies, including multifocal premium lens implants, iFS and iLASIK technology, and elective Clear Lens Exchange among others, but being first is not the goal unto itself!
Why is being first important?
When we decide to be first, it is only after our surgeons have studied and reviewed the FDA clinical trials, discussed the new technology with colleagues across the country, and have attended courses and lectures by the experts involved in those studies. Being first indicates that we are following the FDA and medical community’s approval of the most advanced treatments available, and then carefully considering if they are best for our patients. Being first shows that we are ready to invest in the technologies, training and expertise that offers the best eye care options to our patients.
What is Corneal Cross-Linking?
Also called KXL, this procedure combines Vitamin B2(riboflavin) eye drops and ultra-violet (UV) light to strengthen corneas that have been weakened by disease. The treatment is indicated for selected patients with Keratoconus or Corneal Ectasia who may have previously had no therapeutic options for their disease. KXL is minimally invasive and is performed on an outpatient basis in the office.
Who decides if KXL is right for me?
West Georgia Eye Care Center has the only corneal fellowship trained specialists (James Brooks, Jr., MD and Cynthia Nix, MD) in our region; and, as its name indicates, Corneal Cross-Linking, is a procedure involving the cornea. Your eye doctor may refer you to one of our corneal specialists or you can call for an evaluation. After a complete and thorough eye examination with corneal testing, our physicians will advise you if KXL is recommended for you!
To learn more about KXL: http://avedro.com/en-us/